» Articles » PMID: 32265763

Models Predicting Psychosis in Patients With High Clinical Risk: A Systematic Review

Overview
Specialty Psychiatry
Date 2020 Apr 9
PMID 32265763
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The present study reviews predictive models used to improve prediction of psychosis onset in individuals at clinical high risk for psychosis (CHR), using clinical, biological, neurocognitive, environmental, and combinations of predictors.

Methods: A systematic literature search on PubMed was carried out (from 1998 through 2019) to find all studies that developed or validated a model predicting the transition to psychosis in CHR subjects.

Results: We found 1,406 records. Thirty-eight of them met the inclusion criteria; 11 studies using clinical predictive models, seven studies using biological models, five studies using neurocognitive models, five studies using environmental models, and 18 studies using combinations of predictive models across different domains. While the highest positive predictive value (PPV) in clinical, biological, neurocognitive, and combined predictive models were relatively high (all above 83), the highest PPV across environmental predictive models was modest (63%). Moreover, none of the combined models showed a superiority when compared with more parsimonious models (using only neurocognitive, clinical, biological, or environmental factors).

Conclusions: The use of predictive models may allow high prognostic accuracy for psychosis prediction in CHR individuals. However, only ten studies had performed an internal validation of their models. Among the models with the highest PPVs, only the biological and neurocognitive but not the combined models underwent validation. Further validation of predicted models is needed to ensure external validity.

Citing Articles

Systematic review of clinical prediction models for psychosis in individuals meeting At Risk Mental State criteria.

Hunt A, Law H, Carney R, Mulholland R, Flores A, Tudur Smith C Front Psychiatry. 2024; 15:1408738.

PMID: 39415891 PMC: 11480010. DOI: 10.3389/fpsyt.2024.1408738.


Tunisian Adolescents at CHR for Psychosis: A Pilot Study of Cognitive Remediation in a LMIC.

Abbes Z, Taleb S, Yahia H, Hmidi H, Hajri M, Jelili S Early Interv Psychiatry. 2024; 19(1):e13614.

PMID: 39414393 PMC: 11730502. DOI: 10.1111/eip.13614.


Prognostic models predicting transition to psychotic disorder using blood-based biomarkers: a systematic review and critical appraisal.

Byrne J, Mongan D, Murphy J, Healy C, Fcking M, Cannon M Transl Psychiatry. 2023; 13(1):333.

PMID: 37898606 PMC: 10613280. DOI: 10.1038/s41398-023-02623-y.


Predictors of transition in patients with clinical high risk for psychosis: an umbrella review.

Andreou C, Eickhoff S, Heide M, de Bock R, Obleser J, Borgwardt S Transl Psychiatry. 2023; 13(1):286.

PMID: 37640731 PMC: 10462748. DOI: 10.1038/s41398-023-02586-0.


Ethical Implications of the Use of Language Analysis Technologies for the Diagnosis and Prediction of Psychiatric Disorders.

Loch A, Lopes-Rocha A, Ara A, Gondim J, Cecchi G, Corcoran C JMIR Ment Health. 2022; 9(11):e41014.

PMID: 36318266 PMC: 9667377. DOI: 10.2196/41014.


References
1.
Corcoran C, Keilp J, Kayser J, Klim C, Butler P, Bruder G . Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective. Psychol Med. 2015; 45(14):2959-73. PMC: 5080982. DOI: 10.1017/S0033291715000902. View

2.
McGorry P, Nelson B, Markulev C, Yuen H, Schafer M, Mossaheb N . Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial. JAMA Psychiatry. 2016; 74(1):19-27. DOI: 10.1001/jamapsychiatry.2016.2902. View

3.
van Tricht M, Ruhrmann S, Arns M, Muller R, Bodatsch M, Velthorst E . Can quantitative EEG measures predict clinical outcome in subjects at Clinical High Risk for psychosis? A prospective multicenter study. Schizophr Res. 2014; 153(1-3):42-7. DOI: 10.1016/j.schres.2014.01.019. View

4.
Buchy L, Perkins D, Woods S, Liu L, Addington J . Impact of substance use on conversion to psychosis in youth at clinical high risk of psychosis. Schizophr Res. 2014; 156(2-3):277-80. PMC: 4082820. DOI: 10.1016/j.schres.2014.04.021. View

5.
Mittal V, Walker E, Bearden C, Walder D, Trottman H, Daley M . Markers of basal ganglia dysfunction and conversion to psychosis: neurocognitive deficits and dyskinesias in the prodromal period. Biol Psychiatry. 2010; 68(1):93-9. PMC: 2891189. DOI: 10.1016/j.biopsych.2010.01.021. View